Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Liberty One Investment Management LLC

Liberty One Investment Management LLC reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 17.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,372 shares of the medical equipment provider’s stock after selling 300 shares during the quarter. Liberty One Investment Management LLC’s holdings in Intuitive Surgical were worth $716,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently added to or reduced their stakes in the company. Godsey & Gibb Inc. grew its holdings in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 35 shares during the period. MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical in the third quarter valued at $33,000. Decker Retirement Planning Inc. purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at $36,000. Capital Performance Advisors LLP acquired a new position in shares of Intuitive Surgical during the 3rd quarter worth $38,000. Finally, DT Investment Partners LLC boosted its position in shares of Intuitive Surgical by 80.0% in the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after buying an additional 36 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the stock. BTIG Research lifted their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Citigroup lifted their price objective on Intuitive Surgical from $567.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Wells Fargo & Company increased their target price on Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, December 11th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Finally, Mizuho lifted their price objective on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $554.17.

Intuitive Surgical Stock Up 1.5 %

NASDAQ:ISRG opened at $592.64 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $362.14 and a fifty-two week high of $597.68. The firm’s 50 day moving average is $540.66 and its two-hundred day moving average is $498.77. The company has a market cap of $211.09 billion, a P/E ratio of 95.28, a P/E/G ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Research analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other news, SVP Mark Brosius sold 2,128 shares of the firm’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,095,920.00. Following the transaction, the senior vice president now owns 273 shares of the company’s stock, valued at approximately $140,595. This trade represents a 88.63 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the transaction, the chief financial officer now owns 8,757 shares in the company, valued at $4,730,093.55. The trade was a 2.99 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 48,190 shares of company stock worth $25,012,927 in the last three months. 0.80% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.